Concepedia
Statistics
Publications
27
Citations
1K
H-Index
19
Active since
1992
Affiliations
Sepragen Corporation (United States)(Current)
Pear Therapeutics (United States)
Tethys Research (United States)
Glostrup Hospital
Johns Hopkins University
Robert Gerwien is an author at Sepragen Corporation (United States) specializing in medicine, diabetes mellitus, and life sciences.
Publications per year
1992–2022
Prediction of clinical drug efficacy by classification of drug-induced genomic expression profiles <i>in vitro</i>
Erik C. Gunther, David J. Stone, Robert Gerwien et al. · Proceedings of the National Academy of Sciences · 2003 · 182 citations · Full text
Medicine, Bioinformatics, Pharmacology +14
Development of a Type 2 Diabetes Risk Model From a Panel of Serum Biomarkers From the Inter99 Cohort
Janice A. Kolberg, Torben Jørgensen, Robert Gerwien et al. · Diabetes Care · 2009 · 164 citations · Full text
Medicine, Biostatistics, Endocrinology +16
Treatment parameters modulating regression of human melanoma xenografts by an antibody–drug conjugate (CR011-vcMMAE) targeting GPNMB
Vincent A. Pollack, Enrique Álvarez, Kam Fai Tse et al. · Cancer Chemotherapy and Pharmacology · 2007 · 82 citations
Pharmacy, Oncology, Pharmacology +16
Real-world evidence for a prescription digital therapeutic to treat opioid use disorder
Yuri Maricich, Xiaorui Xiong, Robert Gerwien et al. · Current Medical Research and Opinion · 2020 · 57 citations · Full text
Medicine, Pharmacology, Pharmacotherapy +16
Derivation of a Three Biomarker Panel to Improve Diagnosis in Patients with Mild Traumatic Brain Injury
W. Frank Peacock, Timothy Van Meter, Nazanin Mirshahi et al. · Frontiers in Neurology · 2017 · 44 citations · Full text
Medicine, Neurology, Rehabilitation Medicine +15
1–5 of 27